Surmodics now runs contract coating services from a dedicated facility in Ballinasloe, Ireland, 45 minutes from Galway, putting nearly 50 years of coating expertise on the doorstep of Europe's medical device teams.
Book a Facility Tour See Our Coating CapabilitiesInside Europe's medtech hub
Ireland's medtech sector already runs one of the highest concentrations of device manufacturing in Europe. Surmodics' coating capabilities bring contract medical device coating expertise into that same base, close enough for regular, hands-on collaboration.
European device makers no longer need to ship components to the US for coating feasibility work or commercial production. The Ballinasloe facility handles both, with shorter logistics pathways and closer day-to-day collaboration with your team.
The site was purpose-built for coating work, with clean rooms, testing and process equipment matched to the same specifications Surmodics runs globally. Nothing here is a scaled-down version of the US operation.
Surmodics has worked with device manufacturers on coating challenges since 1979, across neurovascular, cardiovascular, peripheral vascular and ophthalmic applications.
Coatings built around your device
Surmodics offers both UV and thermal-cure coating, built around your device's specific requirements.
Each platform is engineered to deliver industry leading low particulate performance while providing the lubricity, durability, and consistency demanded by today's medical devices.
Built for devices that touch blood.
Heparin and non-heparin surface technologies support blood-contacting devices, reducing thrombogenic risk without compromising the coating's other performance requirements.
Coatings engineered to deliver, not just protect.
Surmodics drug delivery coatings enable release of therapeutic agents from medical devices directly at the target site, with tunable elution profiles ranging from minutes to years. Durable and biodegradable polymer systems backed by decades of clinical use and the regulatory experience to bring drug-device combinations through approval.
Infection control, built into the coating itself.
Antimicrobial functionality can be built into a proven coating system rather than added as a separate step, keeping the device's coating performance and infection-control requirements in one process.
September 23–24, 2026
What to Expect at MedTech Ireland
Surmodics is exhibiting at MedTech Ireland on September 23 and 24, marking the official European launch of our Contract Coating Services. The best way to see what that means in practice is a visit to Ballinasloe itself.
During MedTech Ireland week, we are opening the facility for tours, walking the coating suite and clean rooms, and talking through your specific project with our technical team on site.
Book Your Facility Tour
Spaces during MedTech Ireland week are limited. Pick a time below and we'll confirm your visit.
What to know before you visit
What visitors usually ask
What does the coating feasibility process involve?
Surmodics reviews your substrates, geometry and performance requirements with your engineers, then recommends a coating chemistry and application approach suited to the device.
What is the typical lead time for feasibility and contract coating work?
Standard lead time is 2 weeks from the time your devices arrive with us, but we do support expedited orders.
Can Surmodics support both feasibility studies and full commercial production?
Yes, from early feasibility and coating selection through to commercial manufacturing scale-up, backed by the same technical resources as the wider Surmodics organisation.
